Stephen Gould

Nessuna posizione attualmente

Patrimonio netto: 581 $ in data 30/04/2024

59 anni

Health Technology

Consumer Services

Profilo

Stephen Gould worked as an Executive Director of Translational Oncology at Genentech, Inc. and as a Senior Director at Curis, Inc. He also served as the Chief Scientific Officer at Atreca, Inc. for a year.
Gould holds a doctorate degree from the University of Connecticut Health Center.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
ATRECA, INC. CLASS A 0.02%	11/04/2024	6 757 ( 0.02% )	581 $	30/04/2024

Precedenti posizioni note di Stephen Gould

Società	Posizione	Fine
ATRECA, INC.	Direttore Tecnico/Scientifico/R&S	31/12/2023
CURIS, INC.	Direttore/Membro del Consiglio	-
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Stephen Gould

Formazione di Stephen Gould

University of Connecticut Health Center

Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Stephen Gould

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
ATRECA, INC.	Health Technology
CURIS, INC.	Health Technology

Aziende private	1
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology